Phibro Animal Health Corp (PAHC) Stock
Fundamentals
Recent news

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
PAHC

Best Momentum Stocks to Buy for September 21st
Best Momentum Stocks to Buy for September 21st
PAHC

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
PAHC

Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?
Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?
PAHC
Technicals
Analyst Ratings
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2026Earnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
PAHC

Best Momentum Stocks to Buy for September 21st
Best Momentum Stocks to Buy for September 21st
PAHC

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
PAHC

Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?
Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?
PAHC

4 Stocks With Strong Interest Coverage to Buy as Yields Rise
4 Stocks With Strong Interest Coverage to Buy as Yields Rise
PAHC

Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?
Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?
PAHC

Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
PAHC

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference
PAHC

PAHC or LMAT: Which Is the Better Value Stock Right Now?
PAHC or LMAT: Which Is the Better Value Stock Right Now?
PAHC

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
PAHC
About Phibro Animal Health Corp
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jack Clifford Bendheim | Executive Chairman | 1947 |
| Mr. Daniel M. Bendheim J.D. | CEO, President & Director | 1972 |
| Mr. Glenn C. David | Chief Financial Officer | 1972 |
| Mr. Larry L. Miller | Chief Operating Officer | 1964 |
| Ms. Judith A. Weinstein | Senior VP, General Counsel & Corporate Secretary | 1969 |
| Ms. Lisa Ann Escudero | Senior Vice President of Human Resources | 1962 |
| Mr. Ramon Fuenmayor | President South America Region | — |
| Mr. Samson Li | President of Asia Pacific Region | 1972 |
| Mr. Todd Armstrong | President of North American Region | — |
| Mr. Michael Giambalvo | President of PhibroChem and Ethanol Performance Group | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
Technicals
What the experts say
0 Wall Street Analyst Ratings
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -0.3 | +1.6 | -12.7 | +4.6 | ||||||||
| 2022 | -7.4 | +10.7 | -4.1 | -12.1 | +6.5 | +2.2 | -0.1 | -25.9 | -13.1 | +6.8 | -17.3 | +6.8 |
| 2023 | +12.7 | -1.1 | -3.8 | +2.8 | -16.2 | +6.0 | +5.2 | -5.9 | -12.0 | -14.3 | -14.3 | +17.3 |
| 2024 | -8.6 | +18.2 | -3.4 | +32.4 | +7.8 | -6.5 | +2.6 | |||||
| 2026 | +5.1 | +13.2 | +1.6 | -10.2 |
Corporate actions
Upcoming
No upcoming corporate actions for PAHC



